Coronary Microvascular Dysfunction | SCAI

Each year at the Society for Cardiovascular Angiography & Interventions (SCAI) Annual Scientific Sessions meeting collaborative think tanks involving interventional cardiologists, administrative partners, and members of industry are convened for each SCAI clinical council to discuss topics of particular interest to the group. This document presents the proceedings of the 2023 Coronary Think Tank session, which focused on the topic of coronary microvascular dysfunction (CMD). The goals of this discussion were to identify barriers to diagnosis and treatment and promote actions by the participants, leading to a positive impact on patient care.

All authors: Yader Sandoval, MD, FSCAI; Joaquin E. Cigarroa, MD, MSCAI; George D. Dangas, MD, PhD, MSCAI; Alexandra J. Lansky, MD, MSCAI; Srihari S. Naidu, MD, FSCAI; Sunil V. Rao, MD, FSCAI; Arnold H. Seto, MD, MPA, FSCAI; Samit Shah, MD, PhD, FSCAI; Adhir R. Shroff, MD, MPH, FSCAI; Olga Toleva, MD, FSCAI; Jennifer A. Tremmel, MD, MS, FSCAI; Robert F. Riley, MD, MS, FSCAI; Timothy D. Henry, MD, MSCAI and the SCAI 2023 Think Tank Coronary Consortium: Connie S. Baumgard, MSN, NP; Ilka Bijoux; Lisa Cavaliere; Casey Culbertson; Regina Deible, BSN, FSCAI; Maya El-Sabban, PhD; Jeremy Jackson; Melissa Jackson; Bethany Kalich; Vanessa Long; Amy Newell; Daya Perkins; Krish Ramakrishnan; Karen Russell; Vinod Sharma, PhD; Nick E.J. West, MD; Chrissy Whalen-Morton; Paul Underwood, MD; Kristi Winterfeldt; Cezary Wojcik; and Steve Zizzo. 

Other Guidance Documents

Evidence-based recommendations that promote optimal patient care based on current state-of-the-art science in interventional cardiology.